Found: 1
Select item for more details and to access through your institution.
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
- Published in:
- Breast Journal, 2020, v. 26, n. 9, p. 1857, doi. 10.1111/tbj.13856
- By:
- Publication type:
- Article